Frequently Asked Questions about Indivior PLC (INVVY)

Name: Indivior PLC (INVVY) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Indivior PLC (INVVY) do?

Accepted Answer

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizoph...

Question 2

Is Indivior PLC (INVVY) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of INVVY reveals an Altman Z-Score of 2.80 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($1.24B most recent), help investors decide if INVVY fits their risk profile.

Question 3

What is the current P/E ratio for INVVY?

Accepted Answer

As of the latest trading session, Indivior PLC (INVVY) has a trailing P/E ratio of 18.18.

Question 4

Who is the CEO of Indivior PLC?

Accepted Answer

The current Chief Executive Officer of Indivior PLC is Mark Crossley.

Question 5

What was INVVY's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Indivior PLC reported annual revenues of $1.24B (2025), $1.19B (2024), $1.09B (2023), $0.90B (2022), $0.79B (2021) respectively.

Question 6

Does INVVY pay a dividend?

Accepted Answer

Indivior PLC does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does INVVY have?

Accepted Answer

In its latest reporting period, Indivior PLC generated $-0.09B in Free Cash Flow against a total debt load of $0.35B.

Question 8

What is the Price-to-Book (P/B) ratio of Indivior PLC?

Accepted Answer

The Price-to-Book (P/B) ratio for Indivior PLC (INVVY) is currently -38.95.

Question 9

What is the Price-to-Sales (P/S) ratio of INVVY?

Accepted Answer

Based on trailing twelve-month data, Indivior PLC (INVVY) trades at a Price-to-Sales (P/S) ratio of 3.07.

Question 10

What is Indivior PLC's Return on Equity (ROE)?

Accepted Answer

Indivior PLC (INVVY) has a Return on Equity (ROE) of -98.94%, representing its profitability relative to shareholder equity.

INVVY

How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%

How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%

Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th

Indivior: Still Attractive After FY25 Earnings Beat

Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV)

Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering

Indivior Announces Proposed Convertible Senior Notes Offering